In this study, we demonstrated that VSMC Tfeb deficiency aggravates AAA formation in vivo and that HPОІCD, a compound approved by the Food and Drug Administration for use in humans, limits aneurysm enlargement via activation of TFEB, indicating that pharmacological modulation of TFEB with HPОІCD may be a feasible approach for the treatment of AAA Figure 7K
buy priligy paypal